Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00118534 · ClinicalTrials.gov registry record · NA
Integrating Clinical Practice Guidelines for Smoking Cessation Into Mental Health Care for Veterans With Posttraumatic Stress Disorder
A NA study of Tobacco Use Disorder and Stress Disorders, Post-Traumatic, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 943
- Enrollment target
- 11
- Study locations
NCT00118534: Completed NA study of Tobacco Use Disorder and Stress Disorders, Post-Traumatic, sponsored by US Department of Veterans Affairs.
NCT00118534 is a NA study of Tobacco Use Disorder and Stress Disorders, Post-Traumatic that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 943 participants, above the 226-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (317% higher). The trial reports 11 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00118534, a NA study of Tobacco Use Disorder and Stress Disorders, Post-Traumatic, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 943 participants
- Enrollment target
- 11
- Study locations
Study Summary
The primary study objective is to conduct a prospective, randomized controlled clinical trial that compares the effectiveness of two approaches for delivering smoking cessation treatment for veterans with posttraumatic stress disorder (PTSD). An approach where smoking cessation treatment is integrated into mental health care for PTSD and delivered by mental health providers (experimental condition) will be compared to specialized smoking cessation clinic referral (VA's usual standard of care). Secondary study objectives are to (a) compare the cost outcomes and cost-effectiveness of IC versus USC, (b) identify treatment process variables that explain (mediate) observed differences in smoking abstinence rates for the two study conditions, and (c) determine whether cessation from smoking is associated with worsening of symptoms of PTSD and/or depression.
Primary Outcome
The primary outcome measure was 12-month bio-verified prolonged abstinence from tobacco between 6 and 18 months postrandomization. Prolonged abstinence excluded tobacco use before 6 months postrandomization. Prolonged abstinence defined non-abstinence as 1) smoking for 7 consecutive days or at least once a week for 2 consecutive weeks, or 2) using non-cigarette tobacco for 7 consecutive days or at least once a week for 2 consecutive weeks. Self-reported prolonged abstinence was verified by exhal
Conditions Studied
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Integrated Care for Smoking Cessation in PTSD patients
Study Locations (11)
Alabama
- VA Medical Center, Tuscaloosa - Tuscaloosa
California
- VA San Diego Healthcare System, San Diego - San Diego
District of Columbia
- VA Medical Center, DC - Washington D.C.
Louisiana
- Southeast Veterans Healthcare System, New Orleans - New Orleans
Minnesota
- VA Medical Center, Minneapolis - Minneapolis
Oregon
- VA Medical Center, Portland - Portland
Pennsylvania
- VA Medical Center, Philadelphia - Philadelphia
Rhode Island
- VA Medical Center, Providence - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 943 participants |
| Start Date | 2004-07 |
| Est. Completion | 2009-06 |
| Phase | NA |
What the finished NCT00118534 record still lists
NCT00118534 is an interventional study that assigns participants to a tested intervention. The registered 943 participants enrollment target is mid-sized for trials with a published cap, above the 226-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (317% higher).
The record links to 4 conditions, with Tobacco Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT00118534 lists 11 locations in 11 states (Alabama, California, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT00118534 about?
NCT00118534 is a clinical study titled "Integrating Clinical Practice Guidelines for Smoking Cessation Into Mental Health Care for Veterans With Posttraumatic Stress Disorder". The primary study objective is to conduct a prospective, randomized controlled clinical trial that compares the effectiveness of two approaches for delivering smoking cessation treatment for veterans with posttraumatic stress disorder (PTSD). An approach where smoking cessation treatment is integrat...
What is the current status of trial NCT00118534?
This trial is currently completed. It is a NA study. The enrollment target is 943 participants. The study started on 2004-07. Estimated completion is 2009-06.
What conditions does trial NCT00118534 study?
This clinical trial studies the following conditions: Tobacco Use Disorder, Stress Disorders, Post-Traumatic, Substance-Related Disorders, Mental Health.
What interventions are being tested in trial NCT00118534?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Integrated Care for Smoking Cessation in PTSD patients (BEHAVIORAL).
Who is sponsoring clinical trial NCT00118534?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00118534 being conducted?
This trial has 11 study locations across Alabama, California, District of Columbia, Louisiana, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00118534's enrollment target sits among peer trials
943 3rd of 70 higher than 68 of 70 other Tobacco Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation CM for Veterans With or at Risk for Cancer
RECRUITING · NA
-
Smoking Cessation Behavioral Treatment Study
RECRUITING · NA
-
Contingency Management for Veteran Smokers Undergoing Major Elective Surgery
RECRUITING · NA
-
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
RECRUITING · NA
-
Young Adult Tobacco/Nicotine and Cannabis Co-use
RECRUITING · NA
-
Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05020236 · 944 participants · Phase 3
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- NCT06808334 · 942 participants
CLAiR Pivotal Study
- NCT07190209 · 942 participants · Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- NCT07190222 · 942 participants · Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia